Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Net Margin (2021 - 2025)

HeartSciences' Net Margin history spans 5 years, with the latest figure at 97269.0% for Q4 2025.

  • For Q4 2025, Net Margin fell 9905698.0% year-over-year to 97269.0%; the TTM value through Jan 2026 reached 98078.72%, down 10425361.0%, while the annual FY2025 figure was 203517.79%, 16771215.0% down from the prior year.
  • Net Margin reached 97269.0% in Q4 2025 per HSCS's latest filing, up from 108305.63% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 9314.54% in Q3 2024 to a low of 108305.63% in Q3 2025.
  • Average Net Margin over 5 years is 39703.77%, with a median of 45231.9% recorded in 2022.
  • Peak YoY movement for Net Margin: soared 5596161bps in 2024, then plummeted -11762017bps in 2025.
  • A 5-year view of Net Margin shows it stood at 10048.78% in 2021, then crashed by -389bps to 49178.25% in 2022, then grew by 9bps to 44830.28% in 2023, then skyrocketed by 104bps to 1787.98% in 2024, then tumbled by -5540bps to 97269.0% in 2025.
  • Per Business Quant, the three most recent readings for HSCS's Net Margin are 97269.0% (Q4 2025), 108305.63% (Q3 2025), and 48304.62% (Q2 2025).